Tuesday, October 27, 2009
Paris - Scientists Frenchmen said that some drug therapies for IBD may increase the risk of cancers associated with infection, but, nevertheless, still the benefits of drugs outweigh the risks.
A recent study revealed that the drug "Theopourin" - a drug inhibitor of immunity and inhibitory immune system of the body and is usually used for the treatment of inflammatory bowel disease - can increase the risk of cancers associated with viral infection.
A team of Dr. Laurent Bugery and colleagues Hospital St. Antoine in the French capital Paris to study more than 19 thousand patients suffering from Crohn's disease, and about 30 percent of patients treated with drugs Theopourin, and 14 percent have stopped their use, and 56 percent did not use them at all.
After the follow-up for about three years, the researchers found 23 new cases of cancer nodes.
The researchers said, in a study published the journal "The Lancet", statistical analysis showed that patient who use drugs Theopourin, such as azathioprine which is produced by several companies for the manufacture of pharmaceutical company GlaxoSmithKline (trade name Aimuran), risk of cancer of the lymph nodes at a rate five times, than those who did not use these drugs at all.
And increases the risk of cancer of the lymph nodes, according to researchers, in patients older males who have a longer history of IBD.
0 Comments:
Post a Comment